Mark Chin - 15 Jun 2023 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Mark Chin
Issuer symbol
ITRM
Transactions as of
15 Jun 2023
Transactions value $
$0
Form type
4
Filing time
15 Jun 2023, 17:00:10 UTC
Previous filing
09 Jun 2023
Next filing
23 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITRM Ordinary Shares Options Exercise $0 +15,853 +646% $0 18,306 15 Jun 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Share Units Options Exercise $0 -15,853 -100% $0* 0 15 Jun 2023 Ordinary Shares 15,853 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2 On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.
F3 On June 15, 2022, the reporting person was granted an award of 15,853 RSUs, which vested in full on June 15, 2023.